Pharvaris NV (PHVS)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| CEO: | Berndt A. E. Modig |
| Employees: | 30 |
| Web site: | pharvaris.com |
|
J.H. OORTWEG 21, 2333 CH LEIDEN, LEIDEN, P7, 00000
31 (0)71 203 6410
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Pharvaris N.V. focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE) The company was incorporated in 2015 and is based in Leiden, the Netherlands.